Discover below conference interviews with renowned liver cancer specialists, conducted at ILCA 2018 by ILCA media partners OncLive and Targeted Oncology™.

Click here to view more interviews

Prof. Richard Finn on Role of Lenvatinib in HCC Treatment Paradigm

Dr. Augusto Villanueva on Liquid Biopsy for HCC

Prof. Josep M. Llovet on Biomarkers for HCC

Dr. Primrose on Adjuvant Capecitabine For Biliary Tract Cancer

Dr. Masatoshi Kudo on Cost-Effectiveness Analysis of Lenvatinib Versus Sorafenib

Dr. Ricardo Lencioni on Assessing Response to HCC Therapy

Dr. Ann-Lii Cheng on Tumor Heterogeneity in HCC and Challenges for Clinical Trials

Dr. Abou-Alfa on Key Trends in HCC Research